Related references
Note: Only part of the references are listed.The effect of cantharidins on leukemic stem cells
David C. Dorn et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Targeting and Internalization of Sterically Stabilized Liposome Modified with ZCH-4-2E8
Jingying Zhang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2009)
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab' fragments and single chain Fv
Wilson W. K. Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2008)
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
Y. Kong et al.
LEUKEMIA (2008)
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Tao Yang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts
C Bermejo-Rodriguez et al.
GENOMICS (2006)
Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
K Laginha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior
F Shojaei et al.
DEVELOPMENTAL CELL (2005)
Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates
TM Allen et al.
CLINICAL CANCER RESEARCH (2005)
Enforced expression of an Flt3 internal tandem duplication in human CD34(+) cells confers properties of self-renewal and enhanced erythropoiesis
KY Chung et al.
BLOOD (2005)
Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes
P Sapra et al.
CLINICAL CANCER RESEARCH (2004)
Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab′ fragments
P Sapra et al.
CLINICAL CANCER RESEARCH (2004)
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells
M Harata et al.
BLOOD (2004)
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
ML Immordino et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach
DL Iden et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
CT Jordan et al.
LEUKEMIA (2000)
Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD 117)
A Blair et al.
EXPERIMENTAL HEMATOLOGY (2000)
Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes
P Crosasso et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
